(HPC), Hydroxy propyl methyl cellulose (HPMC), Ethyl cellulose (EC)], Carbomers, acrylates (Evonik polymers) and lipids (waxy and having HLB <5) are generally used to as a carrier matrix which often retard the drug release. Pharmaceutical grade polymers are widely used in twin screw hot melt extrusion (HME) processing. They enable continuous manufacturing of solid solutions and thus extended release dosage forms. However, high processing temperatures and the need for plasticizers sometime force the formulators to explore alternative extrudable materials, including solid lipid excipients [1, 2] . The underlying reason is being that the solid-lipid matrices can be processed via HME at significantly lower temperatures without the need for plasticizers.
Moreover, lipid excipients have a wide range of applications in pharmaceutical industry. Solid glyceryl stearates are commonly used as matrix formers in sustained release tablets and capsules [3] . The melt granulation, most broadly defined as a powder agglomeration with the help of a meltable binder, is applied in numerous pharmaceutical products for a variety of reasons, e.g., to facilitate compression, improve flow, uniformity and to enhance or control dissolution profiles of the drugs used [4] .
Commonly, reported binders such as polyethylene glycol, HPC, HPMC, PEO and HPMC in combination with lipid binders is used in melt granulation [5] [6] [7] . It has been reported in the literature that polymeric binders are not preferable when granulation process is developed for modified or controlled release applications due to solubility in ethanol and susceptibility to dose dumping in hydroalcoholic media [5] [6] [7] . To overcome the problem of polymeric meltable binders solid lipids are one ofmost viableoptions. A numerous pharmaceutical grade lipid excipients have been commercialized by different companies over the past several decades for the development of drug delivery systems [8, 9] . The continuous processing of granules, suitable for continuous blending/compression and for sustained release from a lipid matrix (10)such as glyceryl monostearate (GMS), glyceryl dibehenate, glyceryl tripalmitate, glyceryl tristearate etc has been demonstrated [10] [11] [12] . The physicochemical properties of complex naturally occurring lipid compounds were optimized by modifying their chemical composition (e.g. establishing defined mixtures of esterified fatty acids) and by processing fatty acids with various functional groups such as glycerol, polyethylene glycol, polyglycerol or propylene glycol. By doing so, the melting point (range) and hydrophilic lipophilic balance (HLB) value were adjusted in relation to a given application. Solid lipid excipients with high melting point (long acid chain length) and low HLB value (less polar alcohol) are suitable to retain water soluble drug molecules within the dosage form [13] . Due to their chemical and physical complexity, meltable lipid binders may exhibit a complex behaviour (i.e. melting and crystallization, physical modifications on storage) [14, 15] which has not been thoroughly investigated before.
Niacin is used as a model drug which is an anti-hyperlipidemic agent currently marketed as an oral sustained release dosage form. Niacin is a white, crystalline powder, very soluble in water. Glyceryl Monostearate is a lipid excipient suitable for the controlled release of water soluble drugs. GMS is a mixture of monoacylglycerols mainly monostearoylglycerol together with variable quantities of di and triacylglycerols that has a melting range between 54 0 C and 65 0 C.
GMS is manufactured by different manufacturers worldwide, each has a different process and has a different composition of Monoglycerides, diesters and triesters contents and also different polymorphic forms. And this composition may have different effects on the final formulation or during stability studies.
Therefore, the aim of this study is to evaluate the physical and chemical proerties of two GMS samples manufactured by two different companies. This evaluation is particularly useful for the development of controlled-release formulations as the melting and rheological characteristics of fatty acid binders are most critical parameters to consider, especially when a high amount of lipidic binder mixtures are used. Another objective of this study is to examine a comparative evaluation of GMS as a meltable binder from two different sourcesduring a melt granulation process for sustained release applications.
Materials and Methods:

Materials:
Glyceryl Monostearate(GMS) with brand name Geleol ® was received from Gattefossé India Pvt. , and Talc were used for the tableting study and procured from Sigma Aldrich. All the other reagents and solvents used were of analytical grade.
Samples Preparation:
As described in previous work (J. Hamdani et. al) [16] three samples were prepared for the physical evaluation of GMS.
• Freshly solidified (F) samples: Samples were previously melted by heating at a temperature at least 10 0 C higher than their melting point, solidified at ambient temperature, and stored for 10 hr at room temperature in order to see effect melt processing on lipids.
• Aged (A) samples: Samples were stored for 48 hours at 50 0 C, in order to detect any physical ageing effect (structural or polymorphic changes) associated with lipids bases.
• Untreated (U) samples: Samples without any special treatment (as received).
Differential Scanning Calorimetry:
The melting behavior of the lipophilic binders was evaluated by a Perkin Elmer pyris-6 (USA)
which has an inbuilt computerized data station for thermal analysis. (Perkin-Elmer Corp., CT, USA). Samples of about 5mg were sealed in aluminum pans and scanned between 0 and 150 0 C, at a heating rate of 10 0 C/min under nitrogen flow (20 ml/min) using empty sealed pan as reference.
X-ray Diffraction
Crystallinity of the raw materials, hot-melt extrudates and tablets samples was determined using Lab XRD 6100 Shimadzu x-ray Diffractometer in Theta-Theta mode, Cu anode at 40 kV and 30 mA current. The samples were pulverized in a ball mill chamber with a frequency of 25 s−1 for 30 s. The powdered sample was placed on a glass top loading holder with a depression of 0.2 mm and then gently consolidated. All samples were scanned in a continuous mode within the angular range 5-60° 2θ scale with a scan speed of 2.0° per min and sample width of 0.03°.
Scanning Electron Mircoscopy
The shape and surface morphology of the niacin powder and niacin loaded extrudates were examined using XL 30 Model JEOL 6800 scanning electron microscope made in Japan during analysis. Double-sided carbon tape was affixed on aluminium stubs over which powder sample of niacin was sprinkled and prepared extrudates was attached carefully. The radiation of platinum plasma beam using JFC-1600 auto fine coater was targeted on aluminium stubs for its coating to make layer of 2 nm thick-ness above the sprinkled powder for 25 min. Then, those samples were observed for morphological characterization using a gaseous secondary electron detector (working pres-sure: 0. 
Melt Viscosity measurements
The rheological properties of two GMS samples were determined on the solid material, at different temperatures close to their melting point, using a Viscolead One model viscometer (FungiLab Spain,) spindle L3 at 50 rpm speed. 8-10 gms sample was filled in small sample adaptor which was then attached to the main viscometer. Small sample adaptor was immersed in a digital water bath to maintain the temperature.
Continuous melt granulation processing of Niacin using GMS as matrix former
Continuous melt Granulation
Niacin as received contained a substantial fraction of particles greater than 250 μm. prior to granulation, niacin was passed through sieve no 140 (106 μm threshhold) . The fraction less than 100 μm was collected for further processing and analysis. Melt granulation of niacin with Gelol and Capmul GMS 50K were performed by twin screw extruder instrument (ACG Hot Melt Extruder). Niacin was mixed with GMS and HPC LF at drug/lipid mass ratios of using a V-blender (Wintech Pharmachem Equipment Pvt. Ltd Mumbai) for 5 min. The prepared physical mixtures (PMs) were extruded using a co-rotating single-screw extruder at a screw speed of 50 rpm in order to optimize the formulation and processing parameters prior to scaling up to a twin-screw extruder.
For all experiments, the extruder was operated without a die or transfer plate. Optimized batches were then processed using twin screw extruder instrument (ACG Hot Melt Extruder). The melt extrudate was then milled using a grinder, passed through a 200 μm sieve and packed in HDPE airlock containers for furtheranalyses. HME processing speed, extrusion temperature (Tg mix) and feeding rate were found to be controllable parameters in the process that could affect chemical stability of formulation. All extrusions were performed in triplicate to measure the processing torque and mean residence time (MRT). Melt granulation was processed through the extruder with all temperature control points set at 75 0 C, which is above the melting temperature range of GMS.
Blending and compression
Niacin granules from above step (2.6.1) and other excipients intended to act as a pore Table 1 . 
In vitro dissolution study
An in-vitro drug release of niacinamide tablets was studied byusing dissolution apparatus I-Basket (Electrolab Model TDT 08, India) as per OGD media USFDA datasheet. 900 mL of purified water as the dissolution medium was placed in the dissolution vessels, and the temperature was maintained at 37 ± 0.5 °C. The rotation speed of paddle was 100 rpm. At predetermined time intervals (1, 3, 6, 9, 12 and 20 hour), 10 mL of dissolution medium was removed for determining a drug concentration and was replced by equal amount of fresh medium.
The amount of niacin released in the dissolution medium was measured using a UV spectrophotometer at wavelength of 262 nm. The dissolution study was performed using 6 tablets in triplicate (n=3).
Stability Studies:
Stability studies were conducted on manufcatured tablets at 40 0 C and 75% relative humidity conditions. Thirty tablets were distributed, under ambient conditions, into 50 cc HDPE bottles and induction sealed for 4 s using an induction sealing machine (Eltech, H500 Induction sealer). Packaged tablets were placed in a laboratory stability chamber set for and controlled to 40 0 C and 75% RH. A sealed unopened bottle was collected and evaluated initially, at 1 month and 3 months.
Results and discussion
Pharmaceutical status of GMS and Profile of GMS
Pharmaceutical industry knows various applications of glyceryl monostearate as nonionic emulsifiers, stabilizers, emollients, and plasticizers in a variety of food, pharmaceutical, and cosmetic applications. GMS can be utilized via a novel fluidized hot-melt granulation technique for the production of granules and tablets. Due to its low HLB and hydrophobic nature, it is used to form sustained-release matrices for solid dosage forms such as pellets or tablets. While the names glyceryl monostearate and mono-and diglycerides are used for a variety of esters of longchain fatty acids, the esters fall into two distinct grades which are available in market [18] . From the Table 2 , it is clear that both the selected products comply the pharmacopeial tests. The ranges given for compositions of fatty acids and melting points are also comparable.
40-55 percent monoglycerides:
Polymorphism in Glyceryl Monostearate via solid state analysis
Laine et. al 1988 reported the crystallization rate depends on the size of molecules i.e on the number of carbon atoms in the fatty acid chains. Longer the fatty acid chain, longer would be the crystallization time [19] . Laine et. al 1988 have evaluated the layered structure of tricaprin, trimyristin, and tristearin. Opposite to this Hamdani et. al 2002 have reported that the compritol 888 ATO which is a behenate having the C22 structure reported the substantially higher stability of this lipid [16] . In our case the stearate which is having C21 structure which takes less time as the layered structure disappears fastly. Finally, in order to identify the difference between two GMS samples during processing and at long-term storage conditions the freshly solidified samples (melting 10 0 C above their melting point and cooling at ambient temperature) and aged samples were evaluated with the help of DSC and XRD. [20] They have reported the diffraction data and suggested that GMS was undergoing a slow, but continuous, change in its crystalline state. T. Yajima also characterized the polymorphic forms and effect of heat on the polymorphic content of GMS by using DSC and X-ray diffractions [21] .
It is observed that the endotherms of three different samples are not in accordance with the specifications values. This was unexpected because the specifications termed a melt in between 54.0 to 64 0 C by a sealed-tube method. In the investigation of DSC endotherms, the values are in the range of 64 to 70 0 C. The fact that the reported melting point for pure GMS is 81.5 0 C which is of high-melting component i.e purer material. Raymond et. al. 1968 concluded that changes in the polymorphic form in GMS results in a specific problem, i.e. the stability of a particular formulation that leads to product breakdown (19) .The groupdemonstrated how emulsions made by GMS were unstable due to polymorphic changes during the stability studies. The polymorphic transitions of lipid excipients is critical for drug incorporation and stability, particularly for the nanoparticulate drug delivery systems based on GMS. Polymorphic stability of GMS and its polymorphic transition are very important factors to be considered when designing lipid based formulations [22, 23] .
It was our concern that whether the GMS could behave in the same manner in melt granulation process? To find the answer to this question we have conducted several analytical experiments such as DSC and XRD with different heat treatments to find out the polymorphic nature of two different GMS samples. The presence broad melting endotherm was detected in untreated Geleol sample which is having a peak at 69.25 0 C that suggests all the material is in a melted state. However, the small shift in melting endotherm was observed during storage at 50 0 C for 48 hours with an increase in the height and sharpness of melting endotherm. This was in reported that the rate of crystallization was more rapid for Precirol and highly reliant on the ageing conditions (storage temperature). Similar observations were reported elsewhere that enthalpy change (E) of GMS was dependent on the temperature profile [16, 21, 23] . When the temperature is below 50°C, enthalpy increases, and when the temperature is aove 50° C enthalpy decreases.
With supporting transformation rate equations they have recommended 50° C will be the optimum processing temperature for the transformation of GMS from α form to β form. The more stable β-forms of GMS is a crystalized lattice with high packing density, which have left limited space for drug molecules between the lipid lattice structure. In the melt granulation process drug is granulated with the melted lipid binder under pressure. High pressure treatment can affect the crystal morphology, crystal size distribution, polymorphic properties [24] . Since the drug is covered with lipid binder, the physical and chemical stability of meltable binder plays an important role in final stability of the dosage form.
To understand the polymorphic structure after heat treatment that resembles the melt extrusion step. We have melted both lipids above 10 0 C to the melting points and cooled to room temperature and kept for 24 hours prior to the analytical study. When DSC endotherms were recorded on these samples Geleol has shown shift in melting endotherm also the sharpness of endotherm was also notable. While the untreated Capmul GMS 50K samples show similar broad endotherm (Fig 1(b) ) but after heat treatment the sharpness of endotherm is distinguished.
Practically there is less difference in the peak temperature in the two Capmul sample. In contrast, the Capmul GMS 50 K samples on storing to 50 0 C started shifting the endotherms on higher side. The probable reason that the unstable α form started shifting towards stable β form.
The DSC endotherms showed in Fig. 1(c) permit to confirm the complexity of ageing modifications observed with two GMS samples. And these DSC endotherms are well linked with X-ray diffraction patterns of GMS samples. The x-ray diffraction patterns obtained from two untreated GMS samples permit to observe and that there is no superimposition between Geleol and Capmul GMS 50 K sample and are depicted in Fig. 2 (a-c) . The X-ray diffraction pattern of fresh Geleol shows three major peaks at a 2θ angle of 19.70 0 , 22. 94 0 and 23. 26 0 . Similar nature of diffraction patterns was also observed for Capmul GMS 50K (Fig. 2(b) ). Aged sample (48 hours at 50 •C) of two GMS sources identified and showed similar X-ray diffraction pattern. Moreover, quite different diffraction patterns of two GMS samples were observed in case of freshly solidified samples. Geleol, with individual peaks, were merged in a single broad peak having one intense peak at a 2θ angle of 22.78 0 . This single broad peak confirmed the shifting towards an unstable α form. Contrary to this the in capmul GMS 50K freshly solidified samples crystal structure was well stable as compared to untreated samples. This confirms the capmul GMS can withstand the heat treatment. There is no change in its β form after heat treatment. These observations informs not only the importance of cooling and heating rate during processing on the samples physical state but also the instability of some polymorphic forms of glyceride bases after crystallization. Indeed, during these investigations, the appearance of low melting range endotherms of GMS was only detected when the heating-cooling programs were applied on the samples in DSC instrument, i.e. when DSC thermograms were performed on the freshly solidified samples immediately after crystallization. This is probably the reason why appearance of polymorphs of geleol was detected by the X-ray diffraction. In contrast, this phenomenon was not observed for Capmul GMS 50K, for which DSC curves obtained are The use of lipidic excipients like GMS supposes to consider the evalution of crystalline properties of the material on time, during processing and depending on the temperature conditions adopted during storage. Glycerides with higher melting points and stable polymorphic content are less sensitive to physical modifications and thus to the drug release rate alterations generally associated with lipidic dosage forms [16] .
Particle morphology via SEM and AFM analyses
Surface micrographs of pure niacin and prepared niacin GMS extrudate were captured using SEM technique. The SEM micrograph of pure niacin shows large crystalline forms of drug agglomerates with ordered shape and size Fig. 3 (A) . The cross sectional view at microlevel of the extrudates showed that niacin drug particles are dispered inside the GMS lipid matrices owing to the homogenous blend duirng the high shear melt granulation processing Fig 3 (B and C) . The surface characteristics of niacin GMS extrudates showed rough disordered and crystaline structures Fig 7 (D and E) , which subsequently help to dissolve drug initially when comes in contact with aqueous fluid. The extrudate systems exibit relatively rough and dense structure suggesting that the drug and hydrophobic lipid were mixed uniformly which may be the underlying reason of the sutained release drug formulations. 
Melt Viscosity study of GMS
Another object of this study is the physical evaluation of two GMS samples that have to be used as meltable binders for preparation of sustained-release tablets of niacin in high shear process,
i.e melt granulation. The deformation properties of Gelol and Capmul GMS 50K (untreated) were also studied by using a temperature controlled viscometer. Indeed it's the Capmul GMS 50K which provides good melt viscosity at higher temperature which is due to the presence of its stable β form. In the temperature range 65-70 0 C it holds the structure and may provide good binding properties The comparison of melt viscosity values are represented in the graph. (Fig. 5) . This ability is also depicted in DSC endotherms of Capmul GMS samples.
These results show that use of stable GMS as a meltable binder presenting well distinct melting temperature could be a very interesting tool for preparation of sustained-release tablets by melt granulation, especially when relatively high amounts of lipidic binder have to be used to obtain appropriate drug release properties. As it was essentially discussed in a research paper [16] , the careful control of the product temperature (between 45 and 50 •C) during the pelletisation process permits to control the amount of binder melted, and thus to avoid any "overwetting" phenomenon. 
Melt Granulation of Niacin using GMS as Matrix former
The main disadvantage professed for lipids is their physical variability upon storage and potential influence on drug release. So far, only a few literature references endorsed the instability of drug release to polymorphic changes of lipid excipient and so considering above limitations of the lipids, we hypothesized that the GMS of two sources may impact release and stability profiles of the drug formulations. Hence we attempted to evaluate impact of ageing conditions i.e storage at 40 0 C/ 75 % RH for 90 days on phase transitions of two GMS samples and to correlate these potential changes with in-vitro drug release. Niacin which is a high dose and highly water-soluble drug molecule selected as model API for developing sustained release tablets using GMS. The dose selected is 375 mg. In initial studies, the niacin along with lipid binder, GMS was evaluated in water-insoluble anti-sticking cum bulking agent i.e with microcrystalline cellulose (MCC). This blend was prepared at 70%, 60%, and 50% drug loading and it processed through the extruder with all temperature control points set at 75 0 C, which is above the melting temperature range of GMS.
All formulations had drug content values within the range of 95-105%. Tablet dissolution study provides evidence that the GMS was completely melted and it has coated the niacin. Melt granulation process appear to have initial around, 30%, burst effect. The milling process resulted in particles having a rough surface morphology, which exposes niacin to dissolution media. Though there is an initial burst effect which is also within the acceptance criteria, the twin screw granules are better encapsulated by portion of GMS that melted during the process. Following the burst release from tablets, an additional 70% of the drug was released over next 18 h. (Fig 6 a-b ) . A probable justification, held in the evidence that all of GMS is melted during process, which has coated the particles of niacin. This geometry helps to control the release It was reported that polymorphic changes in lipid-based dosage forms are known to modify drug release and such occurrences were critical to understanding early pharmaceutical dosage forms, such as suppositories and solid lipid matrices [29, 30] . Initial analytical experiments were completed to ensure that the DSC and XRD methodologies were capable of detecting the various polymorphs of GMS samples. Two GMS samples were evaluated by fusion experiments, which confirmed the ability of the DSC methodology to detect the polymorph. Geleol has a peak endotherm at 69.25 0 C which started melting from 56.83 0 C to 75.07 0 C. Also the niacin has major melting endotherm at 137.82 0 C. In the initial niacin with Geleol tablet samples the peak endotherm of niacin and geleol was slightly shifted on lower end i.e at 65.84 0 C and 133.6 0 C (Fig. 7a) . In the accelerated stability conditions i.e 40 0 C/75% RH for 90 days the endotherms of both niacin and geleol was slightly shifted. This observation was correlated with DSC endotherms of heat treated and aged samples (keeping at 50 0 C for 48 hours). There also the shift of endotherms of geleol was identified. Similarly, the Capmul GMS 50 K has endotherm at 67.36 0 . The tablets prepared by using capmul GMS 50 K showed similar endotherms at same positions. During the stability studies, the endotherms were found at same positions (Fig. 7b) .This observation is also correlated with the heat treated and aged samples. The melting endotherm for capmul GMS 50K was found at the same position means a stable polymorphic form of GMS is present in tablets. To recertify this observation X-ray diffraction helped to identify the structural stability of Capmul GMS 50 K samples. The two major diffraction peaks of 19.53 0 & 23.18 0 were observed in lower intensities at similar positions in stability samples. (Fig. 8a) . Both DSC and X-ray Diffraction techniques confirmed the crystalline form of niacin which is stable during the stability study. The stable β form in Capmul GMS also confirmed through XRD. This finding is correlated with findigs of Haupt et al. where he has reported the transformation from an unstable α-form into the energetically stable β-form was important is maintaining the stability of lipid based dosage form.
A benefit of this tempering step is the nonexistence of polymorphic transformations during storage and therefore, missing changes in drug release [31, 32] . Opposite to this observations while reviewing X-ray Diffraction patterns of Geleol samples during the stability study after 3 months there was a single peak observed at 23.24 0 . which is of α form of GMS. This α form was also observed and identified by T. Yajima et.al (2002) . The least stable polymorphic form, α is formed while at very slow cooling rates and this present as amorphous form outside the matrix. While the the stable β form is a crystalline form and is scattered in dense structure [11, 23, 33] . This change in stable β form to an unstable α form affected the dissolution profile at 3 months stability time points (Fig 8b) . It is important to note here that crystalline highly water-soluble niacin was started releasing early from the unstable Geleol coat [34, 35] . When we compared the dissolution profiles of niacin tablets prepared by using Capmul GMS 50 K, there are no any major changes into it. (Fig. 9) . For instance, the transformation from the thermodynamically instable and less dense α-form to the most stable and densely packed β-form had resulted in the reduction of wettability [36] [37] [38] . This is the reason of usage of stable β form, in sustained release dosage forms. Influence of stability condition on Dissolution of tablets-Lipid "Capmul GMS 50K".
Conclusions:
The chemical composition of glycerides used for the manufacturing of solid lipid extrudates was found to have a large influence on solid-state behavior and dissolution profiles.
This study has underlined the significance of considering the physical, thermal and rheological characteristics of GMS in order to superior control the properties of sustained-release formulations.
The chemical and physical complexity of lipophilic binders exhibits quite a complex behaviour, i.e. melting and crystallisation, polymorphism. Two untreated and freshly solidified Geleol and Capmul GMS 50 K samples present different crystal state which was investigated by different analytical techniques. The rate of crystallisation was found to be more rapid for geleol and is highly dependent on ageing and heat treatment process. As a polymorphic form change was detected during melt granulations process it is very important to select the right starting material for drug delivery system. Due to there difference in fatty acid composition the properties the GMS influence release of the drug. In a detailed study of both GMS lipids, the Geleol led to increased incidence of the unstable α-form of the GMS leading to recrystallization of stable β form over time which causes fractal structures on the extrudate surface deteriorating dissolution properties. While the stable β form withstands the heat treatment during melt granulation process. Storage experiments under accelerated and ambient conditions shown a strong influence of temperature on the recrystallization kinetics. The outcomes of this study help to interpret the complex solid-state behaviour of solid lipid extrudates with different compositions which simplify the development of suitable lipid-based oral dosage forms.
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